Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MEPOLIZUMAB vs MESNA: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

MEPOLIZUMAB vs MESNA: Safety Overview

Metric MEPOLIZUMAB MESNA
Total FAERS Reports 43,006 4,892
Deaths Reported 3,158 1,029
Death Rate 7.3% 21.0%
Hospitalizations 13,819 2,155
Average Patient Age 58.9 yrs 39.3 yrs
% Female Patients 67.1% 46.8%
FDA Approval Date N/A Apr 13, 2010
Manufacturer GlaxoSmithKline LLC Hikma Pharmaceuticals USA Inc.
Route SUBCUTANEOUS INTRAVENOUS
Marketing Status Prescription Prescription